A detailed history of Concord Wealth Partners transactions in Zimmer Biomet Holdings, Inc. stock. As of the latest transaction made, Concord Wealth Partners holds 110 shares of ZBH stock, worth $12,322. This represents 0.0% of its overall portfolio holdings.

Number of Shares
110
Previous 110 -0.0%
Holding current value
$12,322
Previous $11,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

SELL
$119.98 - $132.61 $157,173 - $173,719
-1,310 Reduced 92.25%
110 $14,000
Q4 2023

Apr 30, 2024

BUY
$102.72 - $121.7 $13,353 - $15,821
130 Added 10.08%
1,420 $172,000
Q4 2023

Feb 05, 2024

BUY
$102.72 - $121.7 $13,353 - $15,821
130 Added 10.08%
1,420 $172,000
Q3 2023

Apr 30, 2024

SELL
$110.76 - $143.18 $14,398 - $18,613
-130 Reduced 9.15%
1,290 $144,000
Q3 2023

Oct 25, 2023

BUY
$110.76 - $143.18 $130,807 - $169,095
1,181 Added 1083.49%
1,290 $144,000
Q1 2023

Apr 26, 2023

SELL
$121.91 - $130.94 $3,535 - $3,797
-29 Reduced 21.01%
109 $14,000
Q4 2022

Jan 27, 2023

BUY
$104.7 - $128.4 $14,448 - $17,719
138 New
138 $17,000
Q2 2022

Aug 04, 2022

SELL
$102.23 - $133.85 $43,754 - $57,287
-428 Reduced 74.31%
148 $16,000
Q1 2022

Apr 20, 2022

SELL
$108.42 - $129.58 $6,722 - $8,033
-62 Reduced 9.72%
576 $74,000
Q4 2021

Jan 21, 2022

BUY
$115.43 - $146.63 $58,753 - $74,634
509 Added 394.57%
638 $81,000
Q3 2021

Nov 09, 2021

SELL
$136.35 - $158.76 $53,176 - $61,916
-390 Reduced 75.14%
129 $19,000
Q2 2021

Jul 29, 2021

BUY
$152.95 - $173.41 $11,165 - $12,658
73 Added 16.37%
519 $83,000
Q1 2021

May 13, 2021

BUY
$148.16 - $159.71 $65,486 - $70,591
442 Added 11050.0%
446 $71,000
Q4 2020

Feb 16, 2021

BUY
$128.25 - $151.41 $513 - $605
4 New
4 $1,000

Others Institutions Holding ZBH

About ZIMMER BIOMET HOLDINGS, INC.


  • Ticker ZBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 209,820,000
  • Market Cap $23.5B
  • Description
  • Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...
More about ZBH
Track This Portfolio

Track Concord Wealth Partners Portfolio

Follow Concord Wealth Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concord Wealth Partners, based on Form 13F filings with the SEC.

News

Stay updated on Concord Wealth Partners with notifications on news.